SEC Company Response from Xtant Medical Holdings, (XTNT) — Jun 7, 2016
Xtant Medical Holdings, Inc.
Date: June 7, 2016 · CIK: 0001453593 · Accession: 0001144204-16-107343
AI Filing Summary & Sentiment
Referenced dates: June 3, 2016
Letter
Re: Xtant Medical Holdings, Inc. Registration Statement on Form S-1 (File No. 333- 208677)
June 7, 2016
VIA EDGAR
Securities and Exchange Commission
Division of Corporate Finance
100 F Street, N.E.
Washington, D.C. 20549
Ladies and Gentlemen:
By letter dated June 3, 2016, Xtant Medical Holdings, Inc. (the “Company”) requested that the above-referenced Registration Statement be declared effective at 5:00 p.m., Washington, D.C. time, on June 7, 2016, or as soon thereafter as practicable.
The Company hereby requests that its Request for Acceleration of Effectiveness dated June 3, 2016 be withdrawn effective immediately. Should you have any additional questions or concerns, please contact me at (406) 388-0480.
[Remainder of page intentionally left blank]
Very truly yours,
Xtant Medical Holdings, Inc.
Show Raw Text
CORRESP 1 filename1.htm June 7, 2016 VIA EDGAR Securities and Exchange Commission Division of Corporate Finance 100 F Street, N.E. Washington, D.C. 20549 Re: Xtant Medical Holdings, Inc. Registration Statement on Form S-1 (File No. 333- 208677) Ladies and Gentlemen: By letter dated June 3, 2016, Xtant Medical Holdings, Inc. (the “Company”) requested that the above-referenced Registration Statement be declared effective at 5:00 p.m., Washington, D.C. time, on June 7, 2016, or as soon thereafter as practicable. The Company hereby requests that its Request for Acceleration of Effectiveness dated June 3, 2016 be withdrawn effective immediately. Should you have any additional questions or concerns, please contact me at (406) 388-0480. [Remainder of page intentionally left blank] Very truly yours, Xtant Medical Holdings, Inc. By: /s/ John P. Gandolfo Name: John P. Gandolfo Title: Chief Financial Officer cc: James R. Tanenbaum, Esq. Morrison & Foerster LLP